Reina Haque to Drug Administration Schedule
This is a "connection" page, showing publications Reina Haque has written about Drug Administration Schedule.
Connection Strength
0.278
-
Utilization of extended-interval, fixed-dosing of durvalumab, every 4?weeks, in U.S. patients with unresectable stage III NSCLC following concurrent chemoradiation. Future Oncol. 2026 Jan; 22(1):115-121.
Score: 0.232
-
Continuous Combined Estrogen Plus Progestin and Endometrial Cancer: The Women's Health Initiative Randomized Trial. J Natl Cancer Inst. 2016 Mar; 108(3).
Score: 0.029
-
Statin use and risk of prostate cancer in the California Men's Health Study cohort. Cancer Epidemiol Biomarkers Prev. 2007 Nov; 16(11):2218-25.
Score: 0.016